Elbit Medical Technologies Ltd

TASE:EMTC-M Stock Report

Market Cap: ₪13.5m

Elbit Medical Technologies Past Earnings Performance

Past criteria checks 0/6

Elbit Medical Technologies's earnings have been declining at an average annual rate of -53.8%, while the Medical Equipment industry saw earnings growing at 8% annually. Revenues have been growing at an average rate of 87.6% per year.

Key information

-53.8%

Earnings growth rate

-248.2%

EPS growth rate

Medical Equipment Industry Growth15.2%
Revenue growth rate87.6%
Return on equity-193.8%
Net Margin-5,471.6%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Elbit Medical Technologies' (TLV:EMTC) Solid Earnings May Rest On Weak Foundations

Apr 01
Elbit Medical Technologies' (TLV:EMTC) Solid Earnings May Rest On Weak Foundations

Revenue & Expenses Breakdown

How Elbit Medical Technologies makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TASE:EMTC-M Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 240-1510
31 Mar 240-1610
31 Dec 230-1810
30 Sep 230-1110
30 Jun 230-410
31 Mar 230-410
31 Dec 220-510
30 Sep 220-1010
30 Jun 220-1610
31 Mar 220-1510
31 Dec 210-1610
30 Sep 210-200
30 Jun 210100
31 Mar 210200
31 Dec 20012310
30 Sep 20011310
30 Jun 20011210
31 Mar 2009410
31 Dec 190-2100
30 Sep 190500
30 Jun 1901010
31 Mar 1903110
31 Dec 1802710
30 Sep 180010
30 Jun 180-210
31 Mar 180-910
31 Dec 170-1110
30 Sep 170-1510
30 Jun 170-1710
31 Mar 170-1710
31 Dec 160-1910
30 Sep 160-1610
30 Jun 160-1510
31 Mar 160-1610
31 Dec 150-1610
30 Sep 150-1510
30 Jun 150-1110
31 Mar 150-910
31 Dec 140-910
30 Sep 140-1010
30 Jun 140-1310

Quality Earnings: EMTC-M is currently unprofitable.

Growing Profit Margin: EMTC-M is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: EMTC-M is unprofitable, and losses have increased over the past 5 years at a rate of 53.8% per year.

Accelerating Growth: Unable to compare EMTC-M's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: EMTC-M is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-3.3%).


Return on Equity

High ROE: EMTC-M has a negative Return on Equity (-193.75%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/08 00:35
End of Day Share Price 2025/01/06 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Elbit Medical Technologies Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution